Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody

Cytometry

Volumn 23, Issue 3, 1996, Pages 228-240

  Ford, Christopher H J ^a,b   Tsaltas, Georgia C ^a   Osborne, Perry A ^a   Addetia, Karima ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

CEA; Cell solubilization; Endocytosis; Flow cytometry; Immunotargeting; Monoclonal antibodies; SDS PAGE; Western blotting

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG TARGETING; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; CULTURE MEDIA; FLOW CYTOMETRY; HUMANS; HYPERTONIC SOLUTIONS; TUMOR CELLS, CULTURED;

EID: 0029966481     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960301)23:3<228::AID-CYTO6>3.0.CO;2-E     Document Type: Article

References (55)

1. Back N, Soinila S, Virtanen I: Endocytic pathways in the melanotroph of the rat pituitary. Histochem J 25:133-139, 1993.
2. Braslawsky GR, Kadow K, Knipe J, McGoff K, Edson M, Kaneko T, Greenfield RS: Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity Cancer Immunol Immunother 33.367-374, 1991
3. Byers VS, Baldwin RW: Targeted kill: From umbrellas to monoclonal antibodies. J Clin Immunol 12:391-405, 1992.
4. Byers VS, Pawlucyzk I, Berry N, Durrant L, Robins RA, Garnett MC, Price MR, Baldwin RW: Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes. J Immunol 140:4050-4055, 1988.
5. Byers VS, Pawluczyk IZA, Hooi DSW, Price MR, Carroll S, Embleton MJ, Garnett MC, Berry N, Robins RA, Baldwin RW: Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action. Cancer Res 51:1990-1995, 1991.
6. Caron PC, Co MS, Bull MK, Avdalovic M, Queen C, Scheinberg DA: Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies. Cancer Res 52:6701-6767, 1992.
7. Carrière D, Casellas P, Richer G, Gros P, Jansen FK. Endocytosis of an antibody ricin A-chain conjugate (Immuno-A-toxin) adsorbed on colloidal gold Exp Cell Res 156:327-340, 1985.
8. Casalini P, Mezzanzanica D, Canevari S, Della Torre G, Miotti S, Colnaghi MJ, Matzku S: Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor-associated antigen: Analysis of cell binding and internalization. Int J Cancer 48: 284-290, 1991.
9. Casellas P, Brown JP, Gros O, Heltström I, Jansen FK, Poncelet P, Roncucci R, Vidal H, Hellstrom KE: Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97. Int J Cancer 30:437-445, 1982.
10. Chung KN, Saikawa Y, Paik TH, Dixon K, Mulligan T, Cowan KH, Elwood PC: Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates J Clin Invest 91:1289-1294, 1993.
11. Cogliati T, Brusa P, Canevari S, Caldera M, Mezzanzanica D, Dosio F, Cartel L, Colnaghi MI: Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing Mab. Anticancer Res 11:417-422, 1991.
12. Corvalan JRF, Axton CA, Brandon DR, Smith W, Woodhouse C: Classification of anti-CEA monoclonal antibodies. Protides Biol Fluids 31:921-924, 1984.
13. Endo N, Takeda Y, Umemoto N, Kishida K, Watanabe K, Saito M, Kato Y, Hara T: Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: Implications for future preparation of conjugates. Cancer Res 48:3330-3335, 1988.
14. Ford CHJ, Bartlett SE, Casson AG, Marsden CH, Gallant ME: Efficacy and specificity of vindesine monoclonal anti-carcinoembryonic antigen conjugate with nine human cancer cell lines. NCI Monogr 3:107-116, 1987.
15. Ford CHJ, Casson AG: Antibody mediated targeting in the treatment and diagnosis of cancer. An overview. Cancer Chemother Pharmacol 17:197-208, 1986.
16. y specific antibody with potent anti-tumor activity is internalized and degraded in lysosomes. AmJ Pathol 142:607-622, 1993.
17. Garter KC, Abdulaziz Z, Beverley P, Corvalan JRF, Ford C, Lane EB, Mota M, Nash JRG, Pulford K, Stein H, Taylor Papadimitriou J, Woodhouse C, Mason DY: Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 35.1253-1267, 1982.
18. Godal A, Fodstad O, Morgan AC, Pihl A: Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins J Natl Cancer Inst 77:1247-1253, 1986.
19. Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med 29:1795-1809, 1988
20. Haaijman JJ: Labelling of proteins with fluorescent dyes, quantitative aspects of immunofluorescence microscopy. IN: Immunohistochemistry, Cuello AC (ed) J. Wiley & Sons, New York, 1983, pp. 47-85.
21. Hansen SH, Sandvig K, Van Deurs B: Clathrin and HA2 adaptors: Effects of potassium depletion, hypertonic medium, and cytosol acidification. J Cell Biol 121 61-72, 1993.
22. Heuser J: Effects of cytoplasmic acidification on clathrin lattice morphology. J Cell Biol 108:401-411, 1989.
23. Hockey MS, Stokes HJ, Thompson H, Woodhouse C, Macdonald F, Fielding JWL, Ford CHJ: Carcinoembryonic antigen (CEA) expression and heterogeneity in primary and autologous metastastatic gastric tumours demonstrated by a monoclonal antibody. Br J Cancer 49:129-133, 1984.
24. Hopper RA, Ford CHJ: Investigation of methods to detect monoclonal antibody internalisation by human tumor cell lines 12th Annual Medical Students Research Forum, Memorial University, NFLD, Canada 1990 (Abstract).
25. Imamura K, Spriggs D, Kufe D. Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. J Immunol 139:2989-2992, 1987.
26. Kyriakos RJ, Shih Lb, Ong GL, Patel K, Goldenberg DM, Mattes MJ: The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res 52:835-842, 1992
27. Lord JM, Roberts LM, Thorpe PE, Vitetta ES: Immunotoxins. Trends in Biotech 3.175-179, 1985.
28. Mariani G, Kassis AI, Adelstein SJ: Antibody internalization by tumor cells: Implications for tumor diagnosis and therapy. J Nucl Med All Sci 34:51-55, 1990.
29. Matzku S, Brocker EB, Bruggen J, Dippold WG, Tilgen W: Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines. Cancer Res 46:3848-3854, 1986.
30. Matzku S, Moldenhauer G, Kalthoff H, Canevari S, Colnaghi M, Schumacher J, Bihl H: Antibody transport and internalization into tumours. Br J Cancer 62(Suppl X):1-5, 1990.
31. Matzku S, Tilgen W, Kalthoff H, Schmiegel WH, Bröcker EB: Dynamics of antibody transport and internalization. Int J Cancer 2:11-14, 1988.
32. Murphy RF, Powers S, Verdame M, Cantor CR, Pollack R: Flow cytofluorometric analysis of insulin binding and internalization by Swiss 3T3 cells. Cytometry 2.402-406, 1982.
33. Murphy RF, Powers S, Cantor CR: Endosome pH measured in single cells by dual fluorescence flow cytometry: Rapid acidification of insulin to pH 6. J Cell Biology 98:1757-1762, 1984.
34. Murphy RF, Bisaccia E, Cantor CR, Berger C, Edelson RL: Internalization and acidification of insulin by activated lymphocytes. J Cell Physiol 121.351-356, 1984.
35. Olsnes S, Sandvig K, Petersen OW, Van Deurs B: Immunotoxins: Entry into cells and mechanisms of action. Immunol Today 10:291-295, 1989.
36. Orci L, Glick BS, Rothman JE: A new type of coated vesicular carrier that appears not to contain clathrin: Its possible role in protein transport within the Golgi stack. Cell 46.171-184, 1986
37. Osborne PA. Investigation of the use of a fluorescence activated cell sorter (FACS) for studying monoclonal antibody and doxorubicin internalization by human cancer cell lines: Honours Thesis. Memorial University of Newfoundland, St John's, Canada, 1992.
38. Pernis B: Internalization of lymphocyte membrane components. Immunol Today 6:45-49, 1985.
39. Pimm MV, Armitage NC, Perkins AC, Smith W, Baldwin RW: Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts. Cancer Immunol Immunother 19:8-17, 1985.
40. Pulczynski S, Boesen AM, Jensen OM. Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: An immunofluoresceuce and immunoelectron microscopy study Blood 81:1549-1557, 1993.
41. Rosenthal KL, Tompkins WAF, Rawls WE: Factors affecting the expression of carcinoembryonic antigen at the surface of cultured human colon carcinoma cells. Cancer Res 40.4744-4750, 1980
42. Scheinberg DA, Lovett D, Divgi CR: A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: Specific hone marrow targeting and internalization of radionuclide. J Clin Oncol 9:478-490, 1991
43. Serafini T, Orci L, Amherdt M, Brunner M, Kahn RA, Rothman JE: ADP-ribosylation factors is a subunit of the coat of Golgi-derived COP-coated vesicles: A novel role for a GTP-binding protein. Cell 67.239-253, 1991.
44. Shen WC, Ballou B, Ryser HJP, Hakala TR: Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells Cancer Res 46:3912-3916, 1986.
45. Shin LB, Goldenberg DM, Xuan H, Lu H, Sharkey RM, Hall TC: Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier. Cancer Res 51:4192-4198, 1991.
46. Shin LB, Goldenberg DM, Xuan H, Lu HWZ, Mattes MJ, Hall TC. Internalization of an intact doxorubicin immunoconjugate Cancer Immunol Immunother 38:92-98, 1994.
47. Starling JJ, Maciak RS, Law KL, Hinson A, Briggs SL, Laguzza BC, Johnson DA: In vivo antitumor activity of a monoclonal antibody-vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes. Cancer Res 51 2965-2972, 1991.
48. her2 and growth inhibition of cells with her2/neu gene amplification. Int J Cancer 47:933-937, 1991.
49. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979.
50. Tsaltas G, Ford CHJ: Cell membrane antigen-antibody complex dissociation by the widely used glycine-HCl method. An unreliable procedure for studying antibody internalization. Immunol Invest 22: 1-12, 1993.
51. Tsaltas G, Ford CHJ, Gallant ME: Demonstration of monoclonal anticarcinoembryonic antigen (CEA.) antibody internalization by electron microscopy, Western blotting and radioimmunoassay. Anticancer Res 12:2133-2142, 1992.
52. Uadia P, Blair AH, Ghose T, Ferrone S: Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line J Natl Cancer Inst 74:29-35, 1985.
53. Vitetta ES, Fulton RJ, May RD. Till M, Uhr J. Redesigning nature's poisons to create anti-tumor reagents Science 238:1098-1104, 1987.
54. Wargalla UC, Reisfeld RA: Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells. Proc Natl Acad Sci USA 86:5146-5150, 1989.
55. Weltzin R, Lucia-Jandris P, Michetti P, Fields BN, Kraehenbuhl JP, Neutra MR: Binding and transepithelial transport of immunoglobulins by intestinal M cells: Demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol 108:1673-1685, 1989.